NanoVibronix, Inc. financial data

Symbol
NAOV on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
525 Executive Blvd, Elmsford, NY
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Nano Vibronix, Inc. (to 3/25/2014), Nano Vibronix Inc (to 5/5/2005)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 254 % +17.6%
Quick Ratio 111 % +6.72%
Debt-to-equity 72.8 % -28.8%
Return On Assets -43.4 % +40.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.78M shares +67.5%
Common Stock, Shares, Outstanding 2.78M shares +67.5%
Entity Public Float 4.83M USD -72.5%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.78M shares +67.5%
Weighted Average Number of Shares Outstanding, Diluted 2.78M shares +67.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.37M USD +425%
Cost of Revenue 1.2M USD +190%
Research and Development Expense 403K USD +63.8%
Selling and Marketing Expense 787K USD -8.81%
General and Administrative Expense 3.6M USD -5.66%
Operating Income (Loss) -2.61M USD +44.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.79M USD +45.9%
Income Tax Expense (Benefit) 25K USD -7.41%
Net Income (Loss) Attributable to Parent -2.82M USD +22%
Earnings Per Share, Basic -1.28 USD/shares +62.6%
Earnings Per Share, Diluted -1.28 USD/shares +61.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.97M USD -77.1%
Accounts Receivable, after Allowance for Credit Loss, Current 489K USD +589%
Inventory, Net 2.43M USD -21.9%
Assets, Current 5.39M USD +49%
Property, Plant and Equipment, Net 9K USD +28.6%
Operating Lease, Right-of-Use Asset 133K USD +259%
Other Assets, Noncurrent 1K USD -66.7%
Assets 5.7M USD +48.7%
Accounts Payable, Current 92K USD +179%
Liabilities, Current 2.56M USD +7.85%
Operating Lease, Liability, Noncurrent 89K USD
Liabilities 2.86M USD +7.09%
Accumulated Other Comprehensive Income (Loss), Net of Tax -73K USD -32.7%
Retained Earnings (Accumulated Deficit) -67.4M USD -4.36%
Stockholders' Equity Attributable to Parent 2.84M USD +144%
Liabilities and Equity 5.7M USD +48.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -579K USD +51.8%
Net Cash Provided by (Used in) Financing Activities 7K USD
Net Cash Provided by (Used in) Investing Activities -1K USD 0%
Common Stock, Shares Authorized 40M shares 0%
Common Stock, Shares, Issued 2.78M shares +67.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -583K USD +51.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.17M USD +758%
Operating Lease, Liability 133K USD +259%
Payments to Acquire Property, Plant, and Equipment 1K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.83M USD +46%
Lessee, Operating Lease, Liability, to be Paid 152K USD +300%
Operating Lease, Liability, Current 44K USD +18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 58K USD +1833%
Lessee, Operating Lease, Liability, to be Paid, Year One 57K USD +62.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19K USD +1800%
Additional Paid in Capital 70.3M USD +6.86%
Depreciation, Depletion and Amortization 1K USD
Share-based Payment Arrangement, Expense 36K USD -69%
Interest Expense 136K USD +3.03%